A Judge Cleared WBD. Israel Sent ZIM Back to Square One.
Two deals with a government-shaped last gate went in opposite directions this week. Warner Bros. Discovery's judge entered the consent decree and Paramount now expects to close Oct 6. In Israel, the Government Companies Authority ended its review of ZIM's original application and told the buyers to start over. Also: UniFirst finished its FTC production and both sides reportedly expect to talk remedies, Intermex refiled for HSR but California still hasn't reinstated, Synaptics' buyer switched to all-cash, seven new deals joined the tracker, and the Risk/Reward Top 6 got a reshuffle.
71
Active Deals
1.52%
Median Spread
~$651B
Total Value
This Week’s Top Moves
$WBD0.3%
The last gate fell
Last issue's headline on WBD was "settled isn't approved, approved isn't closed." The first half resolved within days. On Sept 30, Judge Araceli Martinez-Olguin entered the consent decree resolving the 12-state lawsuit and lifted the order that had barred closing — six days after a hearing where she told both sides the court was "not a rubber stamp" and gave no timeline. Paramount and WBD said they expect to close on Oct 6. Cash consideration works out to about $31.0167 per share ($31.00 plus $0.00277778 for each day after Sept 30), which is why the spread has collapsed to roughly 0.3%. No judicial or regulatory gate remains; what's left is closing mechanics.
Days after Hapag-Lloyd and FIMI submitted their ten-concession outline, the Israeli government pushed back. On Sept 28, the Finance Ministry formally recommended against the deal and the Prime Minister's Office opposed it, arguing that an Israeli-owned "ZIM Israel" would still depend operationally and commercially on Hapag-Lloyd, so corporate control would not equal strategic independence; the Defense Ministry also opposes, while the Economy Ministry has reportedly softened. On Sept 29, the Government Companies Authority told ZIM it had ended its review of the original application, which is no longer valid. That is not a formal rejection, but the February agreement can't simply continue: a materially revised deal needs fresh approvals from the ZIM, Hapag-Lloyd and FIMI boards and then a new full application, reviewed from the start and likely to take several months. Oct 6 is the date by which ZIM may file a new application (reports differ on whether it covers only the original structure; the buyers aren't expected to simply resubmit it). The outside date is February 2027, extendable to June 2027 if the Authority's approval is the only open condition, and our modeled close sits at the end of that extension. Hapag-Lloyd says the ministries' positions address the original proposal, not its improvements, and that it remains committed. Price is unchanged at $35.00 cash; at an 18% spread, the market is pricing real termination risk.
UniFirst is done. Cintas isn't. Both expect to talk remedies.
On Oct 2, UniFirst finished compiling the data the FTC requested under the June 11 Second Request. Cintas is still producing its response and, per a CTFN report citing an unidentified source, expects to finish by no later than the end of November, aiming for a year-end close. The same report says both companies expect the FTC to ask for a remedy and may offer an upfront proposal to protect the timeline; no remedy has been disclosed, and none of this is a company or FTC statement. The HSR waiting period only restarts 30 days after both sides substantially comply, so a late-November Cintas submission would put the clock at about year-end. The market is not relaxed: the deal spread reportedly widened to about $52 on Oct 2 from about $20 in early August, and Bernstein had already cut implied approval odds from roughly 85% to 70%. Shareholder approval was never the risk; the FTC is the whole story. We moved UNF from #3 to #4 in the Top 6 below.
On Oct 2, Western Union and Intermex refiled their HSR notifications and requested early termination. HSR clearance is valid for only one year, and the original waiting period expired Oct 6, 2025 — so without a refile the deal could not legally close after Oct 6, 2026. That makes the filing a genuine procedural positive (the stock rose on it) but not a new signal of commitment, since it was mandatory. The same 8-K carries the bigger news: the companies said they do not expect California's DFPI to reinstate its approval before Oct 6, and gave no timeline beyond that. The suspension is now seven weeks old, the new 30-day HSR period runs to about Nov 1 absent early termination, and the outside date is Nov 10. Add Intermex's weak Q2 (revenue down 17%, net income down 75%) and the picture is a technical hurdle cleared with the substantive one still open.
On Oct 1, onsemi and Synaptics amended their June agreement from all-stock (1.350 onsemi shares per share, about $7.0B) to all-cash at $123.00 per share, about $5.7B. The trigger was an unsolicited, non-binding competing proposal from an undisclosed third party; Synaptics' board reviewed it and unanimously reaffirmed onsemi, but on the revised terms. The headline value is roughly $1.3B lower, which Synaptics framed as trading stock-price uncertainty for value certainty, and the amended agreement carries no financing condition. For arb purposes the deal is simpler: a flat cash price, no acquirer-price risk, and a spread of about 1.6% against a stock near $121. We've converted the tracker entry to a straight cash deal.
$CBNK — Capital Bancorp → Peoples Bancorp. All-stock, 1.11 PEBO per share (~$728M, ~$43.75 implied at announcement). H1 2027. $CSR — Centerspace → Independence Realty Trust. All-stock, 3.8 IRT per share (~$2.14B). Q4 2026. $VGZ — Vista Gold → Artemis Gold. All-stock, 0.0966 Artemis per share (~US$427M), plan of arrangement. January 2027. $BWIN — The Baldwin Group → Sequence Holdings and the Dell family office. $32.50 cash per Class A share (~$7.7B EV). Q1 2027. $MG — MISTRAS → H.I.G. Capital. $20.35 cash (~$866M EV), 40-day go-shop to Oct 27. Late 2026 or early 2027. $SSTI — SoundThinking → Transom Capital. $8.00 cash tender plus a CVR of up to $3.00 (~$114M upfront EV). Q4 2026. $LFCR — Lifecore Biomedical → Webster Equity Partners. $6.28 cash plus a CVR (up to $663.7M if all milestones are met). Timing not yet disclosed.
Two things stand out. Three of the new names trade above their cash price: MG ($20.65 against $20.35, with the go-shop open through Oct 27, which suggests the market is leaving room for a higher bid, though it could be noise), and SSTI and LFCR, where the CVR has value that our cash-only offer price excludes. And the three stock deals have already slipped as their acquirers' shares fell — at the latest refresh, CSR's implied value was about $55.14 versus $60.46 at announcement, CBNK about $41.60 versus $43.75, and VGZ about $2.61 versus $2.83.
Also This Week
$QRVO — Skyworks says it has every required regulatory clearance (China and South Korea were the last two) and expects to close on or about Oct 5: $32.50 cash plus 0.960 Skyworks shares.
$CCO — the Sept 30 target was missed; CCO's Oct 1 8-K now says early Q4, with one regulatory approval (CFIUS) still outstanding.
$BHF — Bloomberg reported Delaware's regulator questioned Aquarian's founder on Aug 26 about capital sources, use of funds and post-deal plans, and asked for more information. Aquarian says Mubadala's ~$3B is a committed backstop and that it intends to repay a $750M Mubadala loan and buy back $250M of related securities. The Sixth Street/Talcott letter reported Sept 22 is an expression of interest, not a bid — no price and no agreement — so it isn't a floor under the stock.
$NSC — UP and NS announced the STB's Sept 18 denial of the summary-denial motions on Sept 22, alongside a jobs-for-life agreement with SMART-MD that they say gives them majority union support. Opposition remains broad, and comments are due Nov 18.
$GSAT — nothing material. HSR expired in July, Australia's ACCC cleared it July 21, and the FCC review was about day 122 on Oct 4.
$MGLD — Simplify Asset Management has made competing offers above Madison Dearborn's $2.00 (the latest we could verify is $2.25), but holders of ~75% of the voting power had already approved the Madison Dearborn deal by written consent.
Closed: $GBTG (Long Lake, $9.50 cash, ~$6.3B, Sept 29) and $DBRG (SoftBank, $16.00 cash, ~$3.1B).
Binary Events on the Calendar
Oct 5 — $QRVO closing expected (on or about).
Oct 6 — $WBD closing expected. Also the date by which $ZIM may file a new application.
Oct 7 — $ATKR shareholder vote. $ACVA's tender expires the same day, but its HSR period runs to Oct 13, so expect an extension unless early termination arrives.
Oct 15 — $BZH vote; $SMTI HSR waiting period expires.
Oct 19 — $PERF EGM. Insiders control the vote.
Oct 27 — $MG go-shop expires.
Oct 29 — $MKTX shareholder vote and HSR expiry.
Nov 10 — $IMXI outside date.
Nov 18 — $NSC protests and comments due at the STB.
Top 6 by Spread — October 4, 2026
Ticker
Deal
Spread
Key Risk
$BHF
Aquarian / Brighthouse
39.9%
Delaware still examining Aquarian's funding; Dec 6 outside date
$IMXI
Western Union / Intermex
39.0%
DFPI not expected to reinstate before Oct 6; Nov 10 outside date
$UNF
Cintas / UniFirst
20.7%
FTC remedy expected; Cintas to finish by end of November
$ZIM
Hapag-Lloyd / ZIM
18.1%
Original application ended; new filing and fresh review needed
$NSC
Union Pacific / Norfolk Southern
15.6%
Survived, not approved; STB review runs into 2027
$GSAT
Amazon / Globalstar
8.2%
FCC order and satellite milestones remain
Top 6 by Risk-Adjusted Expected Return
#
Ticker
Why
Gross Spread
Annualized
#1
$CCO
Cleanest profile tracked — vote and HSR done, CFIUS the single remaining approval. The Sept 30 target slipped to "early Q4."
1.7%
~56%
#2
$PERF
~81.2% of voting power under support agreements; EGM Oct 19; self-funded.
4.7%
~20%
#3
$GSAT
New. Majority consent already delivered, HSR and Australia cleared; the FCC order is a slow gate, not a binary one.
8.2%
~11%
#4
$UNF
Moved down from #3. Vote done, but an FTC remedy is now expected and a suit is a live downside.
20.7%
~43%
#5
$IMXI
Largest number in the group (short modeled duration); refile was required, DFPI still open.
39.0%
~385%
#6
$BHF
Delaware scrutiny of Aquarian's funding; Mubadala backstop; Talcott letter is interest only (short modeled duration).
39.9%
~231%
Annualized figures use ArbLens's modeled expected close, not a deal's outside date or next catalyst, and aren't probability-weighted. Changes this week: $GSAT enters at #3 and $UNF moves from #3 to #4. $WBD, $QRVO and $SLP are expected to close within days with near-zero spreads, so they're left out rather than ranked. $ZIM and $NSC remain excluded: ZIM for binary political risk, NSC for its long timeline.
If you find ArbLens useful, consider sharing it with at least one person who might benefit — a fellow investor, analyst, or anyone who follows M&A. It’s free, and word of mouth is how this community grows. arblens.com
Real-time deal alerts, spread movements, and analysis as they happen — follow @ArbLens between issues.
Get weekly merger arb insights delivered to your inbox — spreads, regulatory updates, and what to watch next.
For informational purposes only. Nothing here constitutes investment advice. Merger arbitrage involves significant risk including deal failure and loss of capital. Data sourced from public filings and third-party sources. Spreads shown are as of October 4, 2026 and update nightly on arblens.com.